Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MP0317
i
Other names:
MP0317, FAP x CD40 DARPin
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Molecular Partners
Drug class:
CD40 agonist, FAP inhibitor
Related drugs:
‹
ex-vivo autologous dendritic cells vaccine (4)
ABBV-428 (0)
ATOR-4066 (0)
CDX-1140 (0)
CP-870893 (0)
Chi Lob 7/4 (0)
GEN1042 (0)
GM.CD40L cell vaccine (0)
ISF35 (0)
MEDI5083 (0)
NG-350A (0)
SHR-7367 (0)
SL-172154 (0)
YH003 (0)
SEA-CD40 (0)
LVGN7409 (0)
ABBV-927 (0)
AMG994 (0)
ADC-1013 (0)
RG7876 (0)
PYX-107 (0)
AAA614 (2)
177Lu-DOTA-EB-FAPI (0)
177Lu-LNC1004 (0)
BI 765179 (0)
MP0310 (0)
NG-641 (0)
RG7827 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
ex-vivo autologous dendritic cells vaccine (4)
ABBV-428 (0)
ATOR-4066 (0)
CDX-1140 (0)
CP-870893 (0)
Chi Lob 7/4 (0)
GEN1042 (0)
GM.CD40L cell vaccine (0)
ISF35 (0)
MEDI5083 (0)
NG-350A (0)
SHR-7367 (0)
SL-172154 (0)
YH003 (0)
SEA-CD40 (0)
LVGN7409 (0)
ABBV-927 (0)
AMG994 (0)
ADC-1013 (0)
RG7876 (0)
PYX-107 (0)
AAA614 (2)
177Lu-DOTA-EB-FAPI (0)
177Lu-LNC1004 (0)
BI 765179 (0)
MP0310 (0)
NG-641 (0)
RG7827 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login